Compare CREX & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CREX | ICCM |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.1M | 41.4M |
| IPO Year | 2015 | 2013 |
| Metric | CREX | ICCM |
|---|---|---|
| Price | $3.93 | $8.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 24.9K | ★ 8.9M |
| Earning Date | 04-14-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $18,437,000.00 | N/A |
| Revenue This Year | $81.98 | $139.51 |
| Revenue Next Year | $14.82 | $75.66 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.61 | N/A |
| 52 Week Low | $2.19 | $0.13 |
| 52 Week High | $4.42 | $9.54 |
| Indicator | CREX | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 80.14 |
| Support Level | $3.53 | $0.62 |
| Resistance Level | $4.07 | N/A |
| Average True Range (ATR) | 0.20 | 1.51 |
| MACD | 0.00 | 0.57 |
| Stochastic Oscillator | 50.00 | 97.30 |
Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The company operates in one reportable segment, marketing technology solutions. It offers solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks, along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media. Geographically, the company generates maximum revenue from the United States, and the rest from Canada.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.